Home / Recalls / Ranier's Compounding Laboratory / D-1091-2018

D-1091-2018 Class II Terminated

Recalled by Ranier's Compounding Laboratory — Jeannette, PA

Recall Details

Product Type
Drugs
Report Date
August 22, 2018
Initiation Date
July 25, 2018
Termination Date
September 1, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1 vial

Product Description

PRASH 12.2mcg/1.22m/19.29 (Prostaglandin/Phentolamine/Papaverine) Injection, 10 mL vial, Rx only, Ranier's Rx Laboratory, 1107 Lowry Avenue Suite A, Jeannette, PA 15644.

Reason for Recall

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Distribution Pattern

Product was distributed within the state of Pennsylvania.

Code Information

All lots within expiry

Other recalls by Ranier's Compounding Laboratory

  • D-1082-2018 Class II — Avastin 1.25 mg/0.05 mL prefilled syringe, Rx only, Ranier's Rx Laboratory, 1107 (July 25, 2018)
  • D-1086-2018 Class II — Dehydrated Alcohol Solution, packaged in a) 1 mL and b) 3 mL vials, Rx only, Ran (July 25, 2018)
  • D-1083-2018 Class II — Triple P (Prostaglandin/Papaverine/Phentolamine) Injection, 0.008/22.5/0.83 mg/m (July 25, 2018)
  • D-1084-2018 Class II — PR/PA/PH (Prostaglandin/Papaverine/Phentolamine) Injection, 10mcg/30/1mg/mL, 10 (July 25, 2018)
  • D-1081-2018 Class II — DMSO 6.25% Opth Sol, 10 mL droptainer, Rx only, Ranier's Rx Laboratory, 1107 Low (July 25, 2018)
  • D-1088-2018 Class II — Medroxprogesterone 1% Ophthalmic Solution, 10 mL droptainer, Rx only, Ranier's R (July 25, 2018)
  • D-1093-2018 Class II — P/P/P 0.02/40/2mg/mL(Prostaglandin//Papaverine/Phentolamine) Injection, 0.02/40/ (July 25, 2018)
  • D-1089-2018 Class II — Acetylcysteine 10% Oph Solution, 10 mL droptainer, Rx only, Ranier's Rx Laborato (July 25, 2018)
  • D-1092-2018 Class II — PRO/PA/PH/AT 18mcg/1.8mg/ (Prostaglandin//Papaverine/Phentolamine/Atropine) Inje (July 25, 2018)
  • D-1094-2018 Class II — Papav 300/Phent 5mg/10mL (Papaverine/Phentolamine) Injection,300 mg/5 mg/10 mL, (July 25, 2018)